XML 47 R36.htm IDEA: XBRL DOCUMENT v3.10.0.1
Restructuring and Asset Impairment Charges - Summary of Restructuring Charges (Details) - Strategic Growth Initiative Plan - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Dec. 31, 2018
Dec. 31, 2018
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net $ 41 $ 61
Exit-related costs 6 75
Asset impairments and accelerated depreciation and amortization 3 25
Net restructuring charges recognized 50 161
Corporate    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 31 31
Exit-related costs 0 0
Asset impairments and accelerated depreciation and amortization 0 0
Net restructuring charges recognized 31 31
Operating Segments | U.S. Pharmaceutical and Specialty Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 1 4
Exit-related costs 1 7
Asset impairments and accelerated depreciation and amortization 2 6
Net restructuring charges recognized 4 17
Operating Segments | Medical-Surgical Solutions    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 0 10
Exit-related costs 5 12
Asset impairments and accelerated depreciation and amortization 1 2
Net restructuring charges recognized 6 24
Operating Segments | Other    
Restructuring Cost and Reserve [Line Items]    
Severance and employee-related costs, net 9 16
Exit-related costs 0 56
Asset impairments and accelerated depreciation and amortization 0 17
Net restructuring charges recognized $ 9 $ 89